Enzymatic remodelling of antibodies and conjugation with branched toxin linkers

Poster Presentation2 min read 21st Jul 2023

Share via email Share via LinkedIn

Innovative enzymatic approaches for modification of antibodies and conjugation to toxin linkers have gained attention for their ability to attach payloads site-specifically with no or only minor modifications to antibody primary structure.

Click download to find out more.

Download resource

ADCs

Learn more

Infographic

[Infographic] Optimising ADCs through three critical components

View more

Mass spectrometry

Poster Presentation

ADC

ADC

A standardised LC-MS workflow for rapid DAR determination of thiol-conjugated ADCs across a variety of toxin linkers

View more

ADC

ADC

Preview of antibody drug conjugates (ADCs) - The magic bullets animation

Animation

ADC

High Potency API

Antibody drug conjugates (ADC): The magic bullets

View more

ADC

High Potency API

Image taken from antibody drug conjugates ADCs at Sterling animation

Animation

ADC

ADC

Antibody drug conjugates (ADCs) at Sterling

View more

ADC

ADC

Share via email Share via LinkedIn

Popular articles

ADCs at Sterling

News2 min read

GlycoNex Announces Manufacturing Agreement with Sterling for GNX102-ADC Clinical Trial Production Read more

News2 min read

Sterling Expands GMP ADC Manufacturing Capacity at Deeside, UK Read more

Mass spectrometry

Infographic1 min read

Measurement of ADC stability in plasma and serum via mass spectrometry analysis Read more

ADCs

One pager2 min read

Antibody drug conjugation (ADC) overview Read more

Preview of the applying analytical method validation to cell-based potency assays whitepaper

Whitepaper12 min read

Applying analytical method validation to cell-based potency assays Read more

Sterling's Deeside, UK facility

News2 min read

Sterling Expands Bioanalytical Capabilities at Deeside, UK Site Read more

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

Name(Required)

Email(Required)

Company Name(Required)

This field is hidden when viewing the form

Prospect Source

Please click here for our privacy policy

This field is for validation purposes and should be left unchanged.

Service. Passion. Science.

PDMO^® is registered in the U.S. Patent and Trademark Office.

PDMO^® is a registered trademark of Sterling Pharma Solutions Limited (EUIPO and UKIPO). All rights reserved.

Sterling Pharma Solutions Limited. Registration number: 05712796. Registered office address: Sterling Place, Dudley, Cramlington, Northumberland NE23 7QG. Registered in England.